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Methods and Results. To test whether atherosclerosis is associated with a functional abnormality of endothelium-mediated microvascular relaxation affecting coronary blood flow regulation, we compared coronary blood flow responses with cold pressor testing with the response of the coronary vasculature to acetylcholine (an endothelium-dependent vasodilator) and to papaverin (a direct dilator of vascular smooth muscle) in 12 normal control patients and in 19 patients with non-flow-limiting epicardial atherosclerosis (CAD). The drugs were subselectivelyinfused into the left anterior descending coronary artery via a Doppler catheter, and the response in coronary blood flow was assessed by measuring intracoronary blood flow velocity and cross-sectional arterial area (quantitative angiography). Coronary vascular resistance decreased in all normal control patients by -24.1+5.5% (mean±+SD) during the cold pressor test, whereas the CAD patients demonstrated a variable coronary vascular resistance response to cold pressor testing despite comparable changes in the rate-pressure product. The slopes of the acetylcholine dose-blood flow response (percent change in coronary blood flow/dosage of acetylcholine) were significantly reduced in the CAD patients with 38.5±24.8 compared with the normal patients (80.8±28.1; p <0.001). Although coronary blood flow responses to papaverin were slightly but significantly (p<0.05) reduced in the CAD patients, the response to the endothelium-dependent dilator acetylcholine was considerably out of proportion to the papaverin response in these patients compared with the normal patients. The capacity of the coronary system to increase blood flow in response to acetylcholine expressed as relative proportion of the maximal papaverin response was 52.5±18.2% in the normal control patients but only 33 .6±23.6% in the CAD patients (p<0.025 versus normals). There was a significant negative correlation (r=-0.69; p<0.0001) between cold pressor test-induced changes in coronary vascular resistance and the capacity of the coronary system to increase blood flow in response to acetylcholine.
Conclusions. Early stages of epicardial atherosclerosis are associated with an impairment in endothelium-dependent dilation of the coronary microvasculature, indicating that the pathophysiological consequences of atherosclerosis may extend into the human coronary microcirculation. The correlation between cold pressor test-induced coronary vascular resistance changes and the extent of endothelial dysfunction suggests a relation between endothelial function of the microvasculature and coronary blood flow regulation during sympathetic stimulation associated with increased myocardial work. (Circulation 1991; 84:1984 -1992 F urchgott and Zawadzkil first discovered that quently, a variety of additional receptor-dependent the endothelial cell lining was essential for agonists have been identified to mediate endothelithe vasodilator action of acetylcholine on um-dependent relaxation by triggering the release of simple strips of artery in an organ bath. Subseendothelium-derived relaxing factor (EDRF), which induces smooth-muscle relaxation by the stimulation of guanylate cyclase to form intracellular cyclic guanosine monophosphate. 15 However, recent experimental data demonstrated an abnormal endothelium-dependent dilation in the coronary microvasculature of atherosclerotic animals, thereby suggesting that the functional consequences of atherosclerosis may extend into the coronary microcirculation despite the absence of gross atherosclerotic lesions in these vessels. 16, 17 It was the aim of the present study to assess whether endothelium-mediated modulation of the microvasculature plays a role for blood flow regulation in the intact human coronary circulation. Our study was designed to test the hypothesis that patients with non-flow-limiting epicardial atherosclerosis have a functional abnormality of endotheliummediated microvascular relaxation that affects coronary blood flow regulation by the resistance vasculature during sympathetic stimulation. An endothelium-dependent, functional abnormality at the level of the resistance vessels might play an important role in the pathogenesis of myocardial ischemia caused by an impaired regulation of myocardial perfusion in response to neurohumoral stimulation associated with increased myocardial work.
Methods

Study Population
Thirty-one patients undergoing routine diagnostic formed consent was obtained from all patients before the study. Previous studies21 have demonstrated that the dose of 7 mg papaverin, subselectively infused into the left anterior descending artery, elicits a maximal increase in coronary blood flow without affecting global hemodynamic parameters.
Ten minutes after papaverin infusion, acetylcholine was selectively infused into the left anterior descending artery via the Doppler catheter to assess endothelium-dependent increases in coronary blood flow. Increasing dosages of acetylcholine (0.036 ,ug/ml, 0.36 ,ug/ml, and 3.6 ,ug/ml) were infused at an infusion rate of 2 ml/min, lasting 3 minutes for each concentration. The lowest dose of 0.036 ,ug acetylcholine/ml corresponds to an estimated blood concentration in the coronary bed of 10`8 M assuming a blood flow of 80 ml/min. Stepwise acetylcholine infusions were terminated either when vessel occlusion occurred or when the largest dose (3.6 gg/ml) was reached.
Throughout the study, phasic and mean intracoronary blood flow velocity, heart rate, and aortic pressure (via the guiding catheter) were continuously measured. Serial hand injections of nonionic contrast material (Ultravist, Schering AG, Berlin) were performed during control, at the end of cold pressor testing, at re-control after the cold pressor test, at the end of each acetylcholine infusion period, at recontrol after acetylcholine infusion, and after subselective infusion of papaverin. Quantitative Coronary Angiography
Coronary angiography was performed using a simultaneous biplane multidirectional isocentric x-ray system (Siemens Bicor, Erlangen, FRG). The coronary arteries under study were positioned near the isocenter, and special care was taken to avoid overlapping of coronary segments. Biplane cineangiograms were recorded at a frame rate of 25 frames per second. For quantitative analysis, end-diastolic cine frames were videodigitized and stored in the image analysis system (Mipron I, Kontron Electronics, Eching, FRG) in a 512 x512 matrix with an eight-bit gray scale. Using the 12-cm field of view, the resulting pixel density was 7.3 pixels/mm. The geometrical resolution of the x-ray imaging chain is more than 4 line pairs/mm. Quantitative coronary angiography by automatic contour detection was performed by a previously described and validated method using a geometric edge differentiation technique.'421 Calculation of the exact radiological magnification factor of the measured segment was used to scale the data from pixels to millimeters as previously described. 22 The accuracy and precision of this technique as well as the reproducibility of serial measurements under routine clinical conditions have been established in previous studies.14,2l
Quantitative angiography of the epicardial artery was performed for two reasons: first, to determine cross-sectional area of the artery immediately distal to the radiopaque tip of the Doppler catheter to convert the Doppler-derived flow velocity to an estimate of coronary arterial flow, and second, to exclude limitations of coronary artery flow caused by epicardial coronary artery constriction in response to acetylcholine by measuring the most constricting epicardial artery segment distal to the tip of the Doppler catheter as previously suggested by Treasure et al. 23 To determine cross-sectional area of the artery, a 5-7-mm segment was measured immediately distal to the tip of the Doppler catheter. A series of diameter measurements were obtained for each scan line for the length of the arterial segment and displayed in graph form showing diameter versus segment length, and the mean diameter value was calculated. Whenever possible, measurements were performed in both views of the biplane images using the radiopaque tip of the Doppler catheter for identification of corresponding vessel segments, and the vessel's crosssectional area was calculated from both views assuming an elliptical shape. Only single-plane analysis was performed for those coronary segments demonstrating overlapping with other parts of the coronary tree in one view; in those cases (seven of 31 patients; 23%), vessel cross-sectional area was calculated assuming a circular shape. Measurement of the most constricting artery segment was performed in a similar fashion. However, instead of calculating the mean diameter value, the minimal absolute diameter of the analyzed segment was identified in both views and minimal cross-sectional area was calculated.
Flow-limiting constriction was defined as greater than 50% cross-sectional area reduction compared with pre-acetylcholine cross-sectional area of the identical segment.
Data Analysis
For estimation of directional changes in coronary blood flow, a coronary flow index was calculated by The heterogeneous coronary blood flow response to the increased myocardial demand during cold pressor testing in the patients of the CAD group was also evident when the data were plotted so that increases in calculated coronary blood flow indexes were compared with increases in the rate-pressure product. Figure 3 illustrates that there was a statistically significant positive correlation for the normal patients (p<0.005, r=0.77) but there was no relation for the patients of the CAD group.
Response to Acetylcholine and Papaverin
No significant changes in mean aortic pressure or heart rate occurred during subselective infusion of either papaverin or acetylcholine. Table 2 summarizes the epicardial artery crosssectional areas for the two groups during the infusions of acetylcholine and papaverin, respectively. Figure 4 illustrates that the slope of the acetylcholine dose-response relation (percent change in coronary blood flow/dosage of acetylcholine) was significantly (p<0.001) lower with 38.5+24.8 in the patients of the CAD group compared with the normal control patients (80.8+±28.1), mainly resulting from a blunted increase in coronary blood flow at the highest dose of acetylcholine (see Table 3 ). There was no relation between the doseresponse effects of acetylcholine on epicardial crosssectional areas and coronary blood flow indexes (r=0.26, p=0.3), indicating that epicardial artery constriction was not the major determinant of the blunted increase in coronary blood flow in response to acetylcholine in the CAD patients.
The finding of an impaired coronary blood flow response to acetylcholine in the patients of the CAD group was further substantiated when each patient's acetylcholine dose-response was related to papaverin response. The proportion of acetylcholine-induced increases in coronary blood flow relative to papaverininduced increases in blood flow was 52.5+18.2% in the normal control patients but significantly reduced to 33.6+23.6% in the patients of the CAD group (p<0.025 versus normals). Similar results were obtained when each patient's maximal coronary blood flow response to acetylcholine was related to papaverin response (53.3 ± 19.9% in the normal patient group versus 31.5±21.1% in the CAD patient group; p<O.Ol). Thus, the patients with CAD demonstrated an impaired capacity of their coronary system to increase blood flow in response to acetylcholine. When the patients of the CAD group were separately analyzed according to the presence or absence of a history of hypertension, no significant differences were noted: The proportion of acetylcholine-induced increases in blood flow relative to papaverin-induced increases in blood flow was 40.9+28.4% in the 13 patients without hypertension compared with 21.6+24.8% in the six patients with a history of hypertension (p=0.3).
To evaluate any potential relation between acetylcholine-induced vasodilator capacity and coronary vascular resistance response during cold pressor testing, the capacity to increase coronary blood flow by acetylcholine was compared with the change in coronary vascular resistance during the cold pressor test. Figure 5 illustrates that there was a significant negative correlation between cold pressor test-induced changes in coronary vascular resistance and the capacity of the coronary system to increase blood flow in response to acetylcholine. When the patients with a history of hypertension were excluded, the correlation coefficient actually improved to r= -0.72 (p<0.0001, n=25), indicating that the relation was not primarily determined by the coronary vascular response of the patients with arterial hypertension. Thus, a reduction in the capacity of endotheliumdependent coronary vasodilation was associated with a reduced dilator capacity of the coronary resistance vasculature during cold pressor testing.
Discussion
The present investigation demonstrates that, in addition to the paradoxical constrictor response of epicardial conductance vessels, early stages of coronary atherosclerosis (as assessed by angiography) can be associated with an impairment in endotheliumdependent dilation of the microvasculature. These results suggest that the pathophysiological consequences of early atherosclerosis may extend into the human coronary microcirculation. The impairment of endothelium-dependent coronary vasodilation is associated with a reduced dilator capacity of the coronary resistance vasculature during cold pressor testing.
Previous studies assessing endothelium-dependent modulation of vascular tone in the human coronary '17,25 The present investigation extends these findings by demonstrating that the pathophysiological manifestations of atherosclerosis may also extend into the coronary microcirculation of patients without elevated serum cholesterol levels. The patients with evidence of epicardial atherosclerosis exhibited a profoundly impaired capacity to increase blood flow in response to the endotheliumdependent dilator acetylcholine. Although the coronary blood flow response to the smooth muscle relaxant papaverin was also slightly reduced in these patients, the acetylcholine response was considerably out of proportion to the papaverin response. The impaired relaxation to acetylcholine suggests a role for endothelial dysfunction in the coronary microvasculature of these patients. An impaired endotheliumdependent dilator response of the coronary microvasculature implicates that the pathophysiological consequences of early atherosclerosis do extend into the coronary microcirculation. These findings might have important implications regarding regulation of myocardial perfusion in the setting of early atherosclerosis even in the absence of hemodynamically significant epicardial artery lesions. Indeed, an additional important finding of the present study was that the coronary vascular resistance response to cold pressor testing was related to the capacity of the microvasculature to dilate in response to the endothelium-dependent dilator acetylcholine. Those patients who exhibited a blunted cold pressor testinduced increase in coronary blood flow despite augmented metabolic demands leading to a paradoxical increase in coronary vascular resistance during cold pressor testing also demonstrated a strikingly abnormal blood' flow response to the endothelium-dependent dilator acetylcholine. These results indicate that early atherosclerosis may be associated with an abnormal coronary blood flow regulation during cold pressor testing and suggest a relation between endothelial function of the microvasculature and coronary blood flow regulation during sympathetic stimulation associated with increased myocardial demands.
The cause of endothelial dysfunction of the coronary microvessels in patients with early atherosclerosis in this study remains to be defined. The mechanisms underlying abnormal endothelium-dependent vascular relaxation in atherosclerosis may include decreased or abnormal production and/or release of EDRF, destruction of EDRF, and the concomitant release of constricting factors.16 With respect to blood flow regulation during cold pressor testing, the impaired dilator response of the microvasculature might represent a generalized altered sensitivity to coronary vasoconstrictor stimuli in the presence of a dysfunctional endothelium. Recent studies demonstrated that atherosclerosis considerably potentiated vascular constriction to serotonin in the microcirculation of nonhuman primates16 as well as in the human coronary circulation, which exhibited a particularly intense constriction in small distal and collateral vessels. 26 We have recently shown that intracoronary platelet aggregation causes profound constriction of atherosclerotic epicardial arteries in humans in vivo. 27 The potent coronary constrictors neuropeptide Y28 and endothelin29 have been found to constrict distal vessels rather than large coronary arteries. It is conceivable that, in the presence of a dysfunctional endothelium, the release of such a constrictor factor or pressure-induced constriction of the microvessels caused by unopposed myogenic constriction30 may account for the increase in coronary vascular resistance despite augmented metabolic demands.
Nonspecific impairment of coronary vasodilator reserve31,32 was excluded in all patients examined in the present study and thus cannot account for the observed differences in endothelium-mediated dilation of the microvasculature. Patients with hypercholesterolemia, which we have shown profoundly impairs endothelium-dependent dilation of the human coronary resistance vasculature,24 were excluded from the present study. Moreover, the present data failed to demonstrate that hypertension might independently alter endothelial function of the coronary microvasculature or affect the relation between cold pressor test-induced coronary blood flow regulation and endothelial function of the microvasculature. Thus, endothelial dysfunction of the coronary microvessels in the patients of the present study cannot be attributed to the presence of associated diseases that promote the development of atherosclerosis. It should be noted, however, that the patients with a disorder of the coronary microvasculature described as "microvascular" angina31-33 demonstrate a dynamic vascular abnormality that leads to abnormal pacing-induced increases in coronary resistance, which are considerably amplified after ergonovine administration. Recent experimental studies demonstrated that the endothelium inhibits the contractions evoked by ergonovine, and thereby endothelial dysfunction can contribute to the predominant vasoconstrictor response to ergonovine.34 In addition, patients with dilated cardiomyopathy have recently been shown to exhibit a selective impairment in endothelium-dependent dilation of the coronary microvasculature. 23 Thus, there is considerable scope to explore the role of endothelial function for the mechanisms that control the tone of the coronary microvasculature in gaining insight into the pathophysiology of human heart disease.
The most important limitation of the present study is that the data do not prove a cause-and-effect relation between endothelial dysfunction of the coronary microvasculature and the altered response to cold pressor testing. The only way to prove such a cause-and-effect relation would be to demonstrate an altered cold pressor test-induced coronary blood flow regulation after the administration of a selective inhibitor of endothelium-dependent vascular relaxation like NG-monomethyl-L-arginine. Although NGmonomethyl-L-arginine has been infused into the human forearm circulation,8 its selective intracoronary administration might expose the patient to a potentially hazardous risk. However, the results of the present study demonstrate that an abnormal coronary blood flow response to sympathetic stimulation occurred in those patients who also exhibited an impairment in endothelium-dependent dilation of the coronary microvasculature. Thus, although the response to cold pressor testing might be controlled by a separate mechanism apart from endothelial regulation, the relation between endothelial function of the microvasculature and coronary blood flow regulation during sympathetic stimulation suggests that endothelial dysfunction contributes to the impaired coronary blood flow regulation either by direct interference or by allowing separate mechanisms to become operative. Another limitation of the present study refers to the methodology used to assess coronary vascular resistance, which provides no direct data to identify the specific site of the impaired dilator response of the coronary vessels. Thus, although flow-limiting vasoconstriction of epicardial conductance vessels was excluded, the precise site of coronary vascular abnormalities downstream from by guest on July 25, 2017 http://circ.ahajournals.org/ Downloaded from the epicardial vessels cannot be assessed in the intact coronary circulation. Summary Early stages of epicardial atherosclerosis can be associated with an impairment in endothelium-dependent dilation of the coronary microvasculature, indicating that the pathophysiological consequences of early atherosclerosis may extend into the human coronary microcirculation. Endothelial dysfunction of the coronary microvasculature is associated with an impaired coronary blood flow regulation during sympathetic stimulation associated with increased myocardial work and might thereby contribute to the pathogenesis of myocardial ischemia.
